Ignite San Diego

Ignite San Diego

Local business spotlight

Assay Depot Launches Research Exchange With National Cancer Institute

The Center for Cancer Research will enable researchers to find partners and suppliers or track their projects

View Comments ()
|
Email
|
Print

    NEWSLETTERS

    AP
    This microscopy image provided by Dr. Carl June on Wednesday, Aug. 10, 2011 shows immune system T-cells, center, binding to beads which cause the cells to divide. The beads, depicted in yellow, are later removed, leaving pure T-cells which are then ready for infusion to the cancer patients. Scientists are reporting the first clear success with gene therapy to treat leukemia, using the patients' own blood cells to hunt down and wipe out their cancer. They've only done it in three patients so far, but the results were striking: two appear cancer-free up to a year after treatment, and the third had a partial response. Scientists are already preparing to try the approach in other kinds of cancer. (AP Photo/Dr. Carl June)

    Solana Beach-based Assay Depot Inc. has launched an online medical research exchange with the National Cancer Institute’s Center for Cancer Research.

    It has created a relationship-management system that allows cancer researchers to identify experts, initiate research collaborations, exchange files and track entire projects to completion, the company said. Researchers can also view their colleagues’ ratings and reviews, and view details of past transactions.

    Assay Depot, dubbed “the Amazon.com of biomedical research” by its founder and CEO Kevin Lustig, is an online marketplace that pharmaceutical companies use to outsource work in hundreds of drug research areas. 

    The Business Journal is the premier business publication in San Diego. Every day online and each Monday in print, the Business Journal reports on how local business operate and why businesses leaders make the decisions they do. Every story is a dose of insight into how to run a better, more efficient, more profitable business.